메뉴 건너뛰기




Volumn 17, Issue 6, 2015, Pages

HIV-associated Neurocognitive Disorders and Antiretroviral Therapy: Current Concepts and Controversies

Author keywords

Antiretroviral toxicity; CNS penetration effectiveness; CSF escape encephalitis; HIV dementia; HIV associated neurocognitive disorder

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

EID: 84928817597     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-015-0485-6     Document Type: Review
Times cited : (21)

References (45)
  • 1
    • 84886917428 scopus 로고    scopus 로고
    • HIV-associated neurocognitive disorder
    • PID: 24156898
    • Clifford DB, Ances BM. HIV-associated neurocognitive disorder. Lancet Infect Dis. 2013;13:976–86.
    • (2013) Lancet Infect Dis , vol.13 , pp. 976-986
    • Clifford, D.B.1    Ances, B.M.2
  • 2
    • 79952921819 scopus 로고    scopus 로고
    • HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors
    • COI: 1:CAS:528:DC%2BC3MXisVyrtb8%3D, PID: 21174240
    • Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17:3–16.
    • (2011) J Neurovirol , vol.17 , pp. 3-16
    • Heaton, R.K.1    Franklin, D.R.2    Ellis, R.J.3    McCutchan, J.A.4    Letendre, S.L.5    Leblanc, S.6
  • 3
    • 35848953181 scopus 로고    scopus 로고
    • Updated research nosology for HIV-associated neurocognitive disorders
    • COI: 1:STN:280:DC%2BD2snktFyqsQ%3D%3D, PID: 17914061
    • Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789–99.
    • (2007) Neurology , vol.69 , pp. 1789-1799
    • Antinori, A.1    Arendt, G.2    Becker, J.T.3    Brew, B.J.4    Byrd, D.A.5    Cherner, M.6
  • 4
    • 84877847706 scopus 로고    scopus 로고
    • Deficits in self-awareness impact the diagnosis of asymptomatic neurocognitive impairment in HIV
    • PID: 23432363
    • Chiao S, Rosen HJ, Nicolas K, Wendelken LA, Alcantar O, Rankin KP, et al. Deficits in self-awareness impact the diagnosis of asymptomatic neurocognitive impairment in HIV. AIDS Res Hum Retrovir. 2013;29:949–56.
    • (2013) AIDS Res Hum Retrovir , vol.29 , pp. 949-956
    • Chiao, S.1    Rosen, H.J.2    Nicolas, K.3    Wendelken, L.A.4    Alcantar, O.5    Rankin, K.P.6
  • 5
    • 0027209445 scopus 로고
    • Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands
    • COI: 1:STN:280:DyaK3szgsFaitg%3D%3D, PID: 8318174
    • Portegies P, Enting RH, de Gans J, Algra PR, Derix MM, Lange JM, et al. Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands. AIDS. 1993;7:669–75.
    • (1993) AIDS , vol.7 , pp. 669-675
    • Portegies, P.1    Enting, R.H.2    de Gans, J.3    Algra, P.R.4    Derix, M.M.5    Lange, J.M.6
  • 6
    • 0035936622 scopus 로고    scopus 로고
    • HIV-associated neurologic disease incidence changes: multicenter AIDS Cohort Study, 1990–1998
    • COI: 1:STN:280:DC%2BD3M7pt1yhuw%3D%3D, PID: 11160967
    • Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, et al. HIV-associated neurologic disease incidence changes: multicenter AIDS Cohort Study, 1990–1998. Neurology. 2001;56:257–60.
    • (2001) Neurology , vol.56 , pp. 257-260
    • Sacktor, N.1    Lyles, R.H.2    Skolasky, R.3    Kleeberger, C.4    Selnes, O.A.5    Miller, E.N.6
  • 7
    • 0003248215 scopus 로고    scopus 로고
    • AIDS across Europe, 1994-98: the EuroSIDA study
    • COI: 1:STN:280:DC%2BD3crht1KrsQ%3D%3D, PID: 11071184
    • Mocroft A, Katlama C, Johnson AM, Pradier C, Antunes F, Mulcahy F, et al. AIDS across Europe, 1994-98: the EuroSIDA study. Lancet. 2000;356:291–6.
    • (2000) Lancet , vol.356 , pp. 291-296
    • Mocroft, A.1    Katlama, C.2    Johnson, A.M.3    Pradier, C.4    Antunes, F.5    Mulcahy, F.6
  • 8
    • 77952938752 scopus 로고    scopus 로고
    • Cognitive dysfunction in HIV patients despite long-standing suppression of viremia
    • PID: 19996937
    • Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, Schiffer V, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS. 2010;24:1243–50.
    • (2010) AIDS , vol.24 , pp. 1243-1250
    • Simioni, S.1    Cavassini, M.2    Annoni, J.M.3    Rimbault Abraham, A.4    Bourquin, I.5    Schiffer, V.6
  • 9
    • 84866340305 scopus 로고    scopus 로고
    • Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load
    • COI: 1:CAS:528:DC%2BC38XhtlaisrbP, PID: 22614889
    • Peluso MJ, Ferretti F, Peterson J, Lee E, Fuchs D, Boschini A, et al. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load. AIDS. 2012;26:1765–74.
    • (2012) AIDS , vol.26 , pp. 1765-1774
    • Peluso, M.J.1    Ferretti, F.2    Peterson, J.3    Lee, E.4    Fuchs, D.5    Boschini, A.6
  • 10
    • 78650338104 scopus 로고    scopus 로고
    • HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment
    • COI: 1:CAS:528:DC%2BC3MXisFeqsw%3D%3D, PID: 21050119, This study showed detectable CSF HIV RNA in 10 % of HIV-positive individuals with suppressed plasma viral loads
    • Eden A, Fuchs D, Hagberg L, Nilsson S, Spudich S, Svennerholm B, et al. HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment. J Infect Dis. 2010;202:1819–25. This study showed detectable CSF HIV RNA in 10 % of HIV-positive individuals with suppressed plasma viral loads.
    • (2010) J Infect Dis , vol.202 , pp. 1819-1825
    • Eden, A.1    Fuchs, D.2    Hagberg, L.3    Nilsson, S.4    Spudich, S.5    Svennerholm, B.6
  • 11
    • 76749136667 scopus 로고    scopus 로고
    • Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy
    • Canestri A, Lescure FX, Jaureguiberry S, Moulignier A, Amiel C, Marcelin AG, et al. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin infect Dis Off Publ Infect Dis Soc Am. 2010;50:773–8.
    • (2010) Clin infect Dis Off Publ Infect Dis Soc Am , vol.50 , pp. 773-778
    • Canestri, A.1    Lescure, F.X.2    Jaureguiberry, S.3    Moulignier, A.4    Amiel, C.5    Marcelin, A.G.6
  • 12
    • 0036289210 scopus 로고    scopus 로고
    • Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir
    • COI: 1:CAS:528:DC%2BD38XkvFylsb4%3D, PID: 12103427
    • Aquaro S, Calio R, Balzarini J, Bellocchi MC, Garaci E, Perno CF. Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir. Antivir Res. 2002;55:209–25.
    • (2002) Antivir Res , vol.55 , pp. 209-225
    • Aquaro, S.1    Calio, R.2    Balzarini, J.3    Bellocchi, M.C.4    Garaci, E.5    Perno, C.F.6
  • 13
    • 84873043361 scopus 로고    scopus 로고
    • CSF penetration by antiretroviral drugs
    • COI: 1:CAS:528:DC%2BC3sXhvVSmurbL, PID: 23160938
    • Eisfeld C, Reichelt D, Evers S, Husstedt I. CSF penetration by antiretroviral drugs. CNS Drugs. 2013;27:31–55.
    • (2013) CNS Drugs , vol.27 , pp. 31-55
    • Eisfeld, C.1    Reichelt, D.2    Evers, S.3    Husstedt, I.4
  • 14
    • 84859744786 scopus 로고    scopus 로고
    • Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir
    • COI: 1:CAS:528:DC%2BC38Xjsleht7Y%3D, PID: 22217676
    • Best BM, Letendre SL, Koopmans P, Rossi SS, Clifford DB, Collier AC, et al. Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir. J Acquir Immune Defic Syndr. 2012;59:376–81.
    • (2012) J Acquir Immune Defic Syndr , vol.59 , pp. 376-381
    • Best, B.M.1    Letendre, S.L.2    Koopmans, P.3    Rossi, S.S.4    Clifford, D.B.5    Collier, A.C.6
  • 15
    • 84874031270 scopus 로고    scopus 로고
    • Protein-free efavirenz concentrations in cerebrospinal fluid and blood plasma are equivalent: applying the law of mass action to predict protein-free drug concentration
    • COI: 1:CAS:528:DC%2BC3sXltV2htLY%3D, PID: 23295919
    • Avery LB, Sacktor N, McArthur JC, Hendrix CW. Protein-free efavirenz concentrations in cerebrospinal fluid and blood plasma are equivalent: applying the law of mass action to predict protein-free drug concentration. Antimicrob Agents Chemother. 2013;57:1409–14.
    • (2013) Antimicrob Agents Chemother , vol.57 , pp. 1409-1414
    • Avery, L.B.1    Sacktor, N.2    McArthur, J.C.3    Hendrix, C.W.4
  • 16
    • 38349068747 scopus 로고    scopus 로고
    • Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system
    • PID: 18195140
    • Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, et al. Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol. 2008;65:65–70.
    • (2008) Arch Neurol , vol.65 , pp. 65-70
    • Letendre, S.1    Marquie-Beck, J.2    Capparelli, E.3    Best, B.4    Clifford, D.5    Collier, A.C.6
  • 17
    • 84859230231 scopus 로고    scopus 로고
    • Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder
    • PID: 22156215
    • Letendre S. Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder. Top Antivir Med. 2011;19:137–42.
    • (2011) Top Antivir Med , vol.19 , pp. 137-142
    • Letendre, S.1
  • 18
    • 33645510905 scopus 로고    scopus 로고
    • Neuropsychiatric adverse events after switching from an antiretroviral regimen containing efavirenz without tenofovir to an efavirenz regimen containing tenofovir: a report of nine cases
    • PID: 16640107
    • Allavena C, Le Moal G, Michau C, Chiffoleau A, Raffi F. Neuropsychiatric adverse events after switching from an antiretroviral regimen containing efavirenz without tenofovir to an efavirenz regimen containing tenofovir: a report of nine cases. Antivir Ther. 2006;11:263–5.
    • (2006) Antivir Ther , vol.11 , pp. 263-265
    • Allavena, C.1    Le Moal, G.2    Michau, C.3    Chiffoleau, A.4    Raffi, F.5
  • 19
    • 23644444490 scopus 로고    scopus 로고
    • Acute dystonia induced by lamivudine
    • COI: 1:CAS:528:DC%2BD2MXmvVKqsL0%3D, PID: 16062101
    • Song X, Hu Z, Zhang H. Acute dystonia induced by lamivudine. Clin Neuropharmacol. 2005;28:193–4.
    • (2005) Clin Neuropharmacol , vol.28 , pp. 193-194
    • Song, X.1    Hu, Z.2    Zhang, H.3
  • 20
    • 33748071123 scopus 로고    scopus 로고
    • Emtricitabine intolerance in treatment-experienced patients switched from lamivudine: a method of assessing toxicity
    • COI: 1:CAS:528:DC%2BD28Xms1Ogtbs%3D, PID: 16684800
    • Pollock K, Stebbing J, Bower M, Gazzard B, Nelson M. Emtricitabine intolerance in treatment-experienced patients switched from lamivudine: a method of assessing toxicity. J Antimicrob Chemother. 2006;58:227–8.
    • (2006) J Antimicrob Chemother , vol.58 , pp. 227-228
    • Pollock, K.1    Stebbing, J.2    Bower, M.3    Gazzard, B.4    Nelson, M.5
  • 22
    • 11244269806 scopus 로고    scopus 로고
    • More on abacavir-induced neuropsychiatric reactions
    • PID: 15622330
    • Foster R, Taylor C, Everall IP. More on abacavir-induced neuropsychiatric reactions. AIDS. 2004;18:2449.
    • (2004) AIDS , vol.18 , pp. 2449
    • Foster, R.1    Taylor, C.2    Everall, I.P.3
  • 23
    • 84903599799 scopus 로고    scopus 로고
    • Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data
    • PID: 24979445
    • Mollan KR, Smurzynski M, Eron JJ, Daar ES, Campbell TB, Sax PE, et al. Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data. Ann Intern Med. 2014;161:1–10.
    • (2014) Ann Intern Med , vol.161 , pp. 1-10
    • Mollan, K.R.1    Smurzynski, M.2    Eron, J.J.3    Daar, E.S.4    Campbell, T.B.5    Sax, P.E.6
  • 24
    • 76749119501 scopus 로고    scopus 로고
    • Long-term impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals (ACTG 5097s)
    • PID: 20133265
    • Clifford DB, Evans S, Yang Y, Acosta EP, Ribaudo H, Gulick RM, et al. Long-term impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals (ACTG 5097s). HIV Clin Trials. 2009;10:343–55.
    • (2009) HIV Clin Trials , vol.10 , pp. 343-355
    • Clifford, D.B.1    Evans, S.2    Yang, Y.3    Acosta, E.P.4    Ribaudo, H.5    Gulick, R.M.6
  • 25
    • 79955458684 scopus 로고    scopus 로고
    • Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients
    • COI: 1:CAS:528:DC%2BC3MXkvValtb0%3D, PID: 21502598
    • Ciccarelli N, Fabbiani M, Di Giambenedetto S, Fanti I, Baldonero E, Bracciale L, et al. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology. 2011;76:1403–9.
    • (2011) Neurology , vol.76 , pp. 1403-1409
    • Ciccarelli, N.1    Fabbiani, M.2    Di Giambenedetto, S.3    Fanti, I.4    Baldonero, E.5    Bracciale, L.6
  • 26
    • 0037070786 scopus 로고    scopus 로고
    • Drug points: neuropsychiatric complications of nevirapine treatment
    • PID: 11950737
    • Wise ME, Mistry K, Reid S. Drug points: neuropsychiatric complications of nevirapine treatment. BMJ. 2002;324:879.
    • (2002) BMJ , vol.324 , pp. 879
    • Wise, M.E.1    Mistry, K.2    Reid, S.3
  • 27
    • 0037032035 scopus 로고    scopus 로고
    • Nevirapine-induced neuropsychiatric complications, a class effect of non-nucleoside reverse transcriptase inhibitors?
    • PID: 12218402
    • Morlese JF, Qazi NA, Gazzard BG, Nelson MR. Nevirapine-induced neuropsychiatric complications, a class effect of non-nucleoside reverse transcriptase inhibitors? AIDS. 2002;16:1840–1.
    • (2002) AIDS , vol.16 , pp. 1840-1841
    • Morlese, J.F.1    Qazi, N.A.2    Gazzard, B.G.3    Nelson, M.R.4
  • 28
    • 63649139412 scopus 로고    scopus 로고
    • Exacerbation of depression associated with starting raltegravir: a report of four cases
    • PID: 18753871
    • Harris M, Larsen G, Montaner JS. Exacerbation of depression associated with starting raltegravir: a report of four cases. AIDS. 2008;22:1890–2.
    • (2008) AIDS , vol.22 , pp. 1890-1892
    • Harris, M.1    Larsen, G.2    Montaner, J.S.3
  • 29
    • 79952477689 scopus 로고    scopus 로고
    • Severe insomnia related to high concentrations of raltegravir
    • PID: 21368594
    • Eiden C, Peyriere H, Peytavin G, Reynes J. Severe insomnia related to high concentrations of raltegravir. AIDS. 2011;25:725–7.
    • (2011) AIDS , vol.25 , pp. 725-727
    • Eiden, C.1    Peyriere, H.2    Peytavin, G.3    Reynes, J.4
  • 30
    • 70349213595 scopus 로고    scopus 로고
    • Acute onset insomnia associated with the initiation of raltegravir: a report of two cases and literature review
    • PID: 19663717
    • Gray J, Young B. Acute onset insomnia associated with the initiation of raltegravir: a report of two cases and literature review. AIDS Patient Care STDs. 2009;23:689–90.
    • (2009) AIDS Patient Care STDs , vol.23 , pp. 689-690
    • Gray, J.1    Young, B.2
  • 31
    • 84887052771 scopus 로고    scopus 로고
    • Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection
    • COI: 1:CAS:528:DC%2BC3sXhslGhtLfE, PID: 24195548
    • Walmsley SL, Antela A, Clumeck N, Duiculescu D, Eberhard A, Gutierrez F, et al. Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection. N Engl J Med. 2013;369:1807–18.
    • (2013) N Engl J Med , vol.369 , pp. 1807-1818
    • Walmsley, S.L.1    Antela, A.2    Clumeck, N.3    Duiculescu, D.4    Eberhard, A.5    Gutierrez, F.6
  • 32
    • 84903940379 scopus 로고    scopus 로고
    • The relationship of CPE to HIV dementia: slain by an ugly fact?
    • PID: 24907235
    • Berger JR, Clifford DB. The relationship of CPE to HIV dementia: slain by an ugly fact? Neurology. 2014;83:109–10.
    • (2014) Neurology , vol.83 , pp. 109-110
    • Berger, J.R.1    Clifford, D.B.2
  • 33
    • 84985909417 scopus 로고    scopus 로고
    • Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder
    • COI: 1:CAS:528:DC%2BC2cXksVWju78%3D
    • Ellis RJ, Letendre S, Vaida F, Haubrich R, Heaton RK, Sacktor N, et al. Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder. Clin Infect Dis Off Publ Infect Dis Soc Am. 2014;58:1015–22.
    • (2014) Clin Infect Dis Off Publ Infect Dis Soc Am , vol.58 , pp. 1015-1022
    • Ellis, R.J.1    Letendre, S.2    Vaida, F.3    Haubrich, R.4    Heaton, R.K.5    Sacktor, N.6
  • 34
    • 79952020252 scopus 로고    scopus 로고
    • Antiretroviral therapy CNS penetration and HIV-1-associated CNS disease
    • COI: 1:CAS:528:DC%2BC3MXit1artbg%3D, PID: 21339496
    • Garvey L, Winston A, Walsh J, Post F, Porter K, Gazzard B, et al. Antiretroviral therapy CNS penetration and HIV-1-associated CNS disease. Neurology. 2011;76:693–700.
    • (2011) Neurology , vol.76 , pp. 693-700
    • Garvey, L.1    Winston, A.2    Walsh, J.3    Post, F.4    Porter, K.5    Gazzard, B.6
  • 35
    • 84904022110 scopus 로고    scopus 로고
    • Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions
    • PID: 24907236, This large-scale, prospective study showed a negative association of high CPE regimens with risk of HIV dementia but not of other neuroAIDS conditions
    • Caniglia EC, Cain LE, Justice A, Tate J, Logan R, Sabin C, et al. Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions. Neurology. 2014;83:134–41. This large-scale, prospective study showed a negative association of high CPE regimens with risk of HIV dementia but not of other neuroAIDS conditions.
    • (2014) Neurology , vol.83 , pp. 134-141
    • Caniglia, E.C.1    Cain, L.E.2    Justice, A.3    Tate, J.4    Logan, R.5    Sabin, C.6
  • 36
    • 84865482221 scopus 로고    scopus 로고
    • Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study
    • COI: 1:CAS:528:DC%2BC38Xht1ynsbfF
    • Robertson K, Jiang H, Kumwenda J, Supparatpinyo K, Evans S, Campbell TB, et al. Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study. Clin Infect Dis Off Publ Infect Dis Soc Am. 2012;55:868–76.
    • (2012) Clin Infect Dis Off Publ Infect Dis Soc Am , vol.55 , pp. 868-876
    • Robertson, K.1    Jiang, H.2    Kumwenda, J.3    Supparatpinyo, K.4    Evans, S.5    Campbell, T.B.6
  • 37
    • 69549110328 scopus 로고    scopus 로고
    • Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders
    • COI: 1:CAS:528:DC%2BD1MXhtVektbjP, PID: 19731418
    • Tozzi V, Balestra P, Salvatori MF, Vlassi C, Liuzzi G, Giancola ML, et al. Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders. J Acquir Immune Defic Syndr. 2009;52:56–63.
    • (2009) J Acquir Immune Defic Syndr , vol.52 , pp. 56-63
    • Tozzi, V.1    Balestra, P.2    Salvatori, M.F.3    Vlassi, C.4    Liuzzi, G.5    Giancola, M.L.6
  • 38
    • 68449083930 scopus 로고    scopus 로고
    • Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance
    • PID: 19424052
    • Marra CM, Zhao Y, Clifford DB, Letendre S, Evans S, Henry K, et al. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS. 2009;23:1359–66.
    • (2009) AIDS , vol.23 , pp. 1359-1366
    • Marra, C.M.1    Zhao, Y.2    Clifford, D.B.3    Letendre, S.4    Evans, S.5    Henry, K.6
  • 39
    • 84867288689 scopus 로고    scopus 로고
    • Antiretroviral neurotoxicity
    • COI: 1:CAS:528:DC%2BC38XhsVyiu7fM, PID: 22811264
    • Robertson K, Liner J, Meeker RB. Antiretroviral neurotoxicity. J Neurovirol. 2012;18:388–99.
    • (2012) J Neurovirol , vol.18 , pp. 388-399
    • Robertson, K.1    Liner, J.2    Meeker, R.B.3
  • 40
    • 84903595722 scopus 로고    scopus 로고
    • HIV treatment and associated mitochondrial pathology: review of 25 years of in vitro, animal, and human studies
    • PID: 24067671
    • Gardner K, Hall PA, Chinnery PF, Payne BA. HIV treatment and associated mitochondrial pathology: review of 25 years of in vitro, animal, and human studies. Toxicol Pathol. 2013;42:811–22.
    • (2013) Toxicol Pathol , vol.42 , pp. 811-822
    • Gardner, K.1    Hall, P.A.2    Chinnery, P.F.3    Payne, B.A.4
  • 41
    • 27144558377 scopus 로고    scopus 로고
    • Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors
    • COI: 1:CAS:528:DC%2BD2MXhtVWitLjK, PID: 16206458
    • Schweinsburg BC, Taylor MJ, Alhassoon OM, Gonzalez R, Brown GG, Ellis RJ, et al. Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. J Neurovirol. 2005;11:356–64.
    • (2005) J Neurovirol , vol.11 , pp. 356-364
    • Schweinsburg, B.C.1    Taylor, M.J.2    Alhassoon, O.M.3    Gonzalez, R.4    Brown, G.G.5    Ellis, R.J.6
  • 42
    • 84896698109 scopus 로고    scopus 로고
    • Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system
    • COI: 1:CAS:528:DC%2BC2cXjtV2qurY%3D, PID: 24420448
    • Akay C, Cooper M, Odeleye A, Jensen BK, White MG, Vassoler F, et al. Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system. J Neurovirol. 2014;20:39–53.
    • (2014) J Neurovirol , vol.20 , pp. 39-53
    • Akay, C.1    Cooper, M.2    Odeleye, A.3    Jensen, B.K.4    White, M.G.5    Vassoler, F.6
  • 44
    • 77951468353 scopus 로고    scopus 로고
    • Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort
    • COI: 1:CAS:528:DC%2BC3cXkvV2qur8%3D, PID: 20237308
    • Robertson KR, Su Z, Margolis DM, Krambrink A, Havlir DV, Evans S, et al. Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology. 2010;74:1260–6.
    • (2010) Neurology , vol.74 , pp. 1260-1266
    • Robertson, K.R.1    Su, Z.2    Margolis, D.M.3    Krambrink, A.4    Havlir, D.V.5    Evans, S.6
  • 45
    • 33751515147 scopus 로고    scopus 로고
    • CD4+ count-guided interruption of antiretroviral treatment
    • Strategies for Management of Antiretroviral Therapy Study G, El-Sadr WM, Lundgren J, Neaton JD, Gordin F, Abrams D, et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355:2283–96.
    • (2006) N Engl J Med , vol.355 , pp. 2283-2296
    • El-Sadr, W.M.1    Lundgren, J.2    Neaton, J.D.3    Gordin, F.4    Abrams, D.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.